awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q37538760-17E857DC-F9A8-4412-963B-C66166FB88D6
Q37538760-17E857DC-F9A8-4412-963B-C66166FB88D6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37538760-17E857DC-F9A8-4412-963B-C66166FB88D6
Population Pharmacokinetic Modeling To Estimate the Contributions of Genetic and Nongenetic Factors to Efavirenz Disposition.
P2860
Q37538760-17E857DC-F9A8-4412-963B-C66166FB88D6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37538760-17E857DC-F9A8-4412-963B-C66166FB88D6
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
7a45692268823add8e88be7e54486d92bf6059bf
P2860
Efficacy of 400 mg efavirenz versus standard 600 mg dose in HIV-infected, antiretroviral-naive adults (ENCORE1): a randomised, double-blind, placebo-controlled, non-inferiority trial.